4-methylcatechol has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andriambeloson, E; Baillet, C; Callizot, N; Dreano, M; Garotta, G; Vitte, PA | 1 |
| Furukawa, S; Furukawa, Y; Hanaoka, Y; Hayashi, K; Matsukura, S; Ohi, T | 2 |
3 other study(ies) available for 4-methylcatechol and Alloxan Diabetes
| Article | Year |
|---|---|
Interleukin-6 attenuates the development of experimental diabetes-related neuropathy.
Topics: Action Potentials; Animals; Catechols; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electromyography; Interleukin-6; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2006 |
The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats.
Topics: Animals; Antioxidants; Axons; Catechols; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophysiology; Male; Motor Neurons; Nerve Growth Factors; Neural Conduction; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 1994 |
Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats.
Topics: Animals; Catechols; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electric Stimulation; Male; Motor Neurons; Nerve Growth Factors; Neural Conduction; Rats; Rats, Inbred Strains; Sciatic Nerve; Tibial Nerve; Time Factors | 1992 |